Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
The Nucleolus
Biosynthesis of Nucleic Acids
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 8, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
1Brain Tumor Center; Department of Neuro-Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA.
Pyruvate kinase M2 (PKM2) acts as a nuclear histone kinase, promoting cancer by upregulating c-Myc and cyclin D1. Targeting nuclear PKM2 offers a potential strategy for cancer treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: